Abbott Laboratories (ABT)

• Annual Data
• Quarterly Data

Abbott Laboratories, Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders’ Equity

		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014		Dec 31, 2013
	Short-term borrowings
	Trade accounts payable
	Salaries, wages and commissions
	Accrued rebates payable to government agencies
	Accrued other rebates
	All other
	Other accrued liabilities
	Dividends payable
	Income taxes payable
	Current portion of long-term debt
	Current liabilities held for disposition
	Current liabilities
	Long-term debt, excluding current portion
	Defined benefit pension plans and post-employment medical and dental plans for significant plans
	Deferred income taxes
	All other
	Post-employment obligations and other long-term liabilities
	Non-current liabilities held for disposition
	Non-current liabilities
	Total liabilities
	Preferred shares, one dollar par value, none issued
	Common shares, without par value
	Common shares held in treasury, at cost
	Earnings employed in the business
	Accumulated other comprehensive loss
	Total Abbott shareholders’ investment
	Noncontrolling interests in subsidiaries
	Total shareholders’ investment
	Total liabilities and shareholders’ investment

Based on: 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-21).